Read more on . Safe dosing of warfarin is difficult so patients using it have to be monitored frequently by a doctor. In 1977, the company’s first medication to treat thrombosis and embolisms (blood clots), Asasantin was launched and in 1987, the first thrombolytic for acute heart attacks was launched, Actilyse.In 1991, the family owned company shifted management to the Board of Managing Directors and restructured R&D activities and in 1994, the formation of separate companies for each division was announced. Human Pharma An overview of our animal health products can be viewed below. Pradaxa is a blood thinner used to treat blood clots and to prevent strokes or heart attacks in people susceptible to the formation of clots. They are accused of knowingly promoting a drug that could cause serious bleeding and hiding evidence of this dangerous side effect without even having an antidote that could reverse it. Pulmonary embolism is a clot that forms in the lungs, which can also be life-threatening. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and secondary prevention of recurrent DVT and PE in adults. Accessibility Statement; Terms of Use; Data Privacy; Imprint; © 2010-2020 Boehringer Ingelheim. Due to its composition, Jentadueto may also be subject to future lawsuits.The changing healthcare market including the enactment of the Affordable Care Act, known as Obamacare and complexities in the Japanese market has concerned Boehringer management but it continues aggressive development in the diabetes, pulmonary and oncology arena.Boehringer cut 1,100 jobs with the U.S. closure of Ben Venue in Ohio and has announced plans to cut 500 to 600 jobs in Germany due to lagging sales that dropped 3 percent overall in the first half of 2014, with a 5.4 percent drop in the pharmaceuticals market and has said they will be looking for additional cost cutting measures.It is clear that Pradaxa lawsuits have also impacted the company’s financial future and may continue to do so as additional lawsuits are filed.Our goal at Drug Dangers is to help keep the public informed of medical devices and medications with serious side effects. The studies’ authors concluded that doctors needed to be cautious in prescribing Pradaxa, that the balance of benefits and risks may not be as straightforward as the drug maker had suggested up to that point.Between 2010 and 2013 individuals who either suffered excessive bleeding or who had lost family members to bleeding while taking Pradaxa, filed thousands of lawsuits and liability claims against Boehringer Ingelheim. The company had 2013 revenue of nearly $18 billion with products in Consumer Health Care (over-the-counter), Animal Health, and Prescription Medicine.Boehringer describes their mission as “Value through Innovation” and has produced several unique medications including Flomax for enlarged prostate, Viramune for HIV in adults and infants over the age of 15 days, Spiriva for pulmonary disorders, Tradjenta for diabetes and Pradaxa for blood clot prevention.Though Boehringer has maintained a reputation of advanced research and philanthropy, it has been warned by the Food and Drug Administration on more than one occasion for poor quality control and safety violations at some production facilities.
Animal Health Products. The settlement was not easy to achieve with the FDA stating that Pradaxa still had a good benefit to risk ratio and with the drug company claiming that it is widely known that any anticoagulant comes with a risk of bleeding.